s6y

First Tracks Biotherapeutics, Inc.

Ticker
TRAX
CIK
2091349
Industry
Pharmaceutical Preparations
Formerly
Biopharma Company, Inc.

Financials 3

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026

News 9

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing

Ownership 60

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 3/A Initial statement of beneficial ownership of securities

All 60 ownership filings

Prospectus 10

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. S-1 General form of registration statement for all companies including face-amount certificate companies
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  7. S-1 General form of registration statement for all companies including face-amount certificate companies
  8. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Other 18

  1. SCHEDULE 13G
  2. SCHEDULE 13G/A
  3. EFFECT Notice of Effectiveness
  4. SCHEDULE 13G/A
  5. 144 Filing for proposed sale of securities under Rule 144
  6. SCHEDULE 13G
  7. SCHEDULE 13G
  8. SCHEDULE 13G
  9. SCHEDULE 13G
  10. SCHEDULE 13G

All 18 other filings